Levocetirizine Dihydrochloride
Product Images NDC 70934-235

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 70934-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 235 30 Rev A 01 19)

Packaging label for Levocetirizine Dihydrochloride Tablets, USP 5 mg, with a count of 30 tablets. The label indicates the product is Rx only, includes storage instructions, and provides the NDC number 70934-235-30. The manufacturer is listed as Denton Pharma, Inc. DBA Northwind Pharmaceuticals, located in Bethlehem, NY. The label also displays batch and expiration placeholders and a QR code.*

FDA Label Image

Str (Levocetirizine Structure)

Chemical structure of Levocetirizine Dihydrochloride showing the molecular arrangement with chlorophenyl groups, a piperazine ring, and dihydrochloride salt indication (.2HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.